Looks like you’re on the UK site. Choose another location to see content specific to your location

Home Industry News Bayer HealthCare wins EU approval for contraceptive Jaydess

Bayer HealthCare wins EU approval for contraceptive Jaydess

6th December 2012

Bayer HealthCare has announced that its new contraceptive product Jaydess has been approved for sale by European regulators.

The new low-dose levonorgestrel-releasing intrauterine system is designed for placement in the uterus for the prevention of pregnancy for up to three years, making it more convenient than needing to rely on a daily pill.

It is a flexible plastic T-shaped device that releases a small amount of the hormone levonorgestrel into the bloodstream and offers a rapid return to usual levels of fertility after removal.

The manufacturer expects to launch the product in a number of EU markets in the second quarter of 2013.

Dr Kemal Malik, member of the Bayer HealthCare executive committee and head of global development, said: "Our new intrauterine system has been primarily developed for women who are looking for a reliable, convenient long-term contraceptive option with a very low hormonal dose."

This comes after the company received EU approval for its new Eylea therapy for neovascular age-related macular degeneration last month.ADNFCR-8000103-ID-801501730-ADNFCR

We currently have 9 jobs available in Pharmacy industry, find your perfect one now.

Stay informed

Receive the latest industry news, Tips
and straight to your inbox.